Search Results for "finasteride"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for finasteride. Results 1 to 3 of 3 total matches.
A Fixed-Dose Combination of Finasteride and Tadalafil (Entadfi) for BPH (online only)
The Medical Letter on Drugs and Therapeutics • Sep 05, 2022 (Issue 1658)
A Fixed-Dose Combination of Finasteride and Tadalafil (Entadfi) for BPH (online only) ...
The FDA has approved Entadfi (Veru), a fixed-dose
combination of the 5α-reductase inhibitor
finasteride and the phosphodiesterase type 5 (PDE5)
inhibitor tadalafil, for initial treatment of benign
prostatic hyperplasia (BPH) in men with an enlarged
prostate; use of the drug is limited to 26 weeks.
Entadfi is the first 5α-reductase inhibitor/PDE5
inhibitor combination to become available in the
US. Finasteride (Proscar, and generics) and tadalafil
(Cialis, and generics) are also available separately.
Drugs for Benign Prostatic Hyperplasia
The Medical Letter on Drugs and Therapeutics • May 02, 2022 (Issue 1649)
finasteride and dutasteride can
reduce prostatic volume and decrease urinary retention and
the need ...
About 60% of men ≥60 years old have clinically
relevant prostatic enlargement due to benign prostatic
hyperplasia (BPH). The goals of treatment are to
decrease lower urinary tract symptoms and to prevent
disease progression and complications such as acute
urinary retention. The American Urologic Association's
guidelines for treatment of BPH were recently updated.
Phosphodiesterase-5 Inhibitors for Alzheimer's Disease?
The Medical Letter on Drugs and Therapeutics • Oct 31, 2022 (Issue 1662)
arterial hypertension. Tadalafil is
also approved alone (Cialis) and in combination
with finasteride ...
A reader asked us to review use of the
phosphodiesterase-5 (PDE5) inhibitor sildenafil for
treatment of Alzheimer's disease (AD).